Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2018-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00262-018-2135-yPMID 29497780PMCID PMC5930126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autoantibodies against tumor-associated antigens in the early detection of lung cancer.

  2016cited by this paper
• Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma

  2015cited by this paper
• Restricted Boltzmann Machines for Classification of Hepatocellular Carcinoma

  2014cited by this paper
• Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.

  2014cited by this paper
• Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?

  2014cited by this paper
• Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

  2014cited by this paper
• Autoantibody Response to Murine Double Minute 2 Protein in Immunodiagnosis of Hepatocellular Carcinoma

  2014cited by this paper
• A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma

  2014cited by this paper
• GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer

  2013cited by this paper
• Real-time liquid biopsy in cancer patients: fact or fiction?

  2013cited by this paper
• Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma.

  2008cited by this paper
• Autoantibodies to tumor‐associated antigens: reporters from the immune system

  2008cited by this paper
• Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies.

  2006cited by this paper
• Recursive partitioning as an approach to selection of immune markers for tumor diagnosis.

  2003cited by this paper
• Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.

  2003cited by this paper
• Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.

  2001cited by this paper
• A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late Development

  1999cited by this paper
• A Novel Cytoplasmic Protein with RNA-binding Motifs Is an Autoantigen in Human Hepatocellular Carcinoma

  1999cited by this paper
• Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein

  1997cited by this paper
• Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma.

  1993cited by this paper
• Estimating the Dimension of a Model

  1978cited by this paper

• Do circulating autoantibodies commonly found in healthy individuals reduce cancer risk?

  2025cites this paper
• A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma

  2023cites this paper
• B cell profiles, antibody repertoire and reactivity reveal dysregulated responses with autoimmune features in melanoma

  2023cites this paper
• Advancements in Oncoproteomics Technologies: Treading toward Translation into Clinical Practice

  2023cites this paper
• Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma

  2022cites this paper
• Beneficial autoimmunity improves cancer prognosis

  2021cites this paper
• Anti-Cancer Auto-Antibodies: Roles, Applications and Open Issues

  2021cites this paper
• Neoantigen Specific T Cells Derived From T Cell-Derived Induced Pluripotent Stem Cells for the Treatment of Hepatocellular Carcinoma: Potential and Challenges

  2021cites this paper
• Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment

  2021cites this paper
• Serum Anti-14-3-3 Zeta Autoantibody as a Biomarker for Predicting Hepatocarcinogenesis

  2021cites this paper
• Apoptosis-induced translocation of centromere protein F in its corresponding autoantibody production in hepatocellular carcinoma

  2021cites this paper
• ReviewHugo de Jonge 1

  2021cites this paper
• Screening and Evaluating Novel Autoantibodies Based on Proteomic Chips in Diagnosis of Esophageal Squamous Cell Carcinoma

  2021cites this paper
• Metals, autoimmunity, and neuroendocrinology: Is there a connection?

  2020cites this paper
• Autoantibody signature in hepatocellular carcinoma using seromics

  2020cites this paper
• Cyclic Peptide Mimotopes for the Detection of Serum Anti–ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma

  2020cites this paper
• Serological Biomarkers for Early Detection of Hepatocellular Carcinoma: A Focus on Autoantibodies against Tumor-Associated Antigens Encoded by Cancer Driver Genes

  2020cites this paper
• Overexpression of p62/IMP2 can Promote Cell Migration in Hepatocellular Carcinoma via Activation of the Wnt/β-Catenin Pathway

  2019cites this paper
• Establishment and validation of an immunodiagnostic model for prediction of breast cancer

  2019cites this paper
• A panel of autoantibodies against tumor-associated antigens in the early immunodiagnosis of lung cancer.

  2019cites this paper
• Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma

  2019cites this paper
• Liver cancer-associated changes to the proteome: what deserves clinical focus?

  2018cites this paper
• TGF-β as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives

  2018cites this paper